Summary

Global mutation detection kits in genome editing market are valued approximately at USD 126.9 million in 2020 and is anticipated to grow with a healthy growth rate of about 17.3% over the forecast period 2021-2027. Mutation detection kits are medical products which offer a simple method for the identification of insertions and deletions in mammalian cells. Mutation detection kits usually contains all of the reagents which are required for PCR - based identification of insertions and deletions which are generated in genome of the cell treated with engineered nucleases such as ZFNs (zinc-finger nucleases), CRISPR/Cas9 or TALENs (transcription-activator-like effector nucleases). Growing adoption of personalized medicine and increasing demand for genetically modified organisms and synthetic genes are some of the factors that are expected to significantly contribute towards the growth of global mutation detection kits in genome editing market during the forecast period. In addition, emerging applications of genome editing technologies in cell and gene therapy area provides lucrative growth opportunities to the market. Also, there has been significant research studies in the market. For instance, in 2021 researchers at Keck Graduate Institute (KGI, U.S.), Vilnius University (Lithuania, Europe) and UC Berkeley (U.S.) developed a handheld device powered with CRISPR (clustered regularly interspaced short palindromic repeats) technology, named CRISPR-Chip. Researchers combined CRISPR and graphene electronic transistors for the detection of specific gene mutations in a small timeframe. Also, in 2021, a research study was published which stated that TALEN was found to be a suitable tool for compact DNA studies, as per NCBI. Such research studies and developments are expected to fuel further innovations in the market and hence promote the market growth. However, regulatory and ethical challenges regarding the use of gene modified products is expected to hamper the growth of global mutation detection kits in genome editing market during the forecast years.

The regional analysis of the global mutation detection kits in genome editing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America accounts for the largest share in terms of market revenue in the global mutation detection kits in genome editing market over the forecast period 2021-2027. Presence of a significant number of market players in the region, investments in research and development, continuous technological developments by key market players etc. supplements the market growth in North America. However, Asia Pacific is expected to emerge as the fastest growing region owing to factors such as rise in the prevalence of different diseases, technological advancements, etc.

Major market player included in this report are:
Thermo Fisher Scientific
Takara Bio Inc.
Integrated DNA Technologies, Inc.
Lucigen
Promega Corporation
GenScript
Synthego
New England Biolabs
Applied Biological Materials, Inc. (abm)
Bio-Rad Laboratories

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:
CRISPR/Cas9
ZFN
TALENs/MegaTALs
Meganucleases
Others
By End-use:
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Contract Research Organizations
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Mutation Detection Kits In Genome Editing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

ページTOPに戻る

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Mutation Detection Kits In Genome Editing Market, by Region, 2019-2027 (USD Billion)
1.2.2. Mutation Detection Kits In Genome Editing Market, by Technology, 2019-2027 (USD Billion)
1.2.3. Mutation Detection Kits In Genome Editing Market, by End-use, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Mutation Detection Kits In Genome Editing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Mutation Detection Kits In Genome Editing Market Dynamics
3.1. Mutation Detection Kits In Genome Editing Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing adoption of personalized medicine
3.1.1.2. Increasing demand for genetically modified organisms and synthetic genes
3.1.2. Market Restraints
3.1.2.1. Regulatory and ethical challenges regarding the use of gene modified products
3.1.3. Market Opportunities
3.1.3.1. Emerging applications of genome editing technologies in cell and gene therapy area
Chapter 4. Global Mutation Detection Kits In Genome Editing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Top Investment Opportunities
4.5. Top Winning Strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk assessment: COVID -19 Impact
5.1. Assessment of the Overall Impact of COVID-19 on the industry
5.2. Pre COVID-19 and Post COVID-19 Market Scenario
Chapter 6. Global Mutation Detection Kits In Genome Editing Market, by Technology
6.1. Market Snapshot
6.2. Global Mutation Detection Kits In Genome Editing Market by Technology, Performance - Potential Analysis
6.3. Global Mutation Detection Kits In Genome Editing Market Estimates & Forecasts by Technology 2018-2027 (USD Billion)
6.4. Mutation Detection Kits In Genome Editing Market, Sub Segment Analysis
6.4.1. CRISPR/Cas9
6.4.2. ZFN
6.4.3. TALENs/MegaTALs
6.4.4. Meganucleases
6.4.5. Others
Chapter 7. Global Mutation Detection Kits In Genome Editing Market, by End-use
7.1. Market Snapshot
7.2. Global Mutation Detection Kits In Genome Editing Market by End-use, Performance - Potential Analysis
7.3. Global Mutation Detection Kits In Genome Editing Market Estimates & Forecasts by End-use 2018-2027 (USD Billion)
7.4. Mutation Detection Kits In Genome Editing Market, Sub Segment Analysis
7.4.1. Biotechnology and Pharmaceutical Companies
7.4.2. Academic and Government Research Institutes
7.4.3. Contract Research Organizations
Chapter 8. Global Mutation Detection Kits In Genome Editing Market, Regional Analysis
8.1. Mutation Detection Kits In Genome Editing Market, Regional Market Snapshot
8.2. North America Mutation Detection Kits In Genome Editing Market
8.2.1. U.S. Mutation Detection Kits In Genome Editing Market
8.2.1.1. Technology breakdown estimates & forecasts, 2018-2027
8.2.1.2. End-use breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Mutation Detection Kits In Genome Editing Market
8.3. Europe Mutation Detection Kits In Genome Editing Market Snapshot
8.3.1. U.K. Mutation Detection Kits In Genome Editing Market
8.3.2. Germany Mutation Detection Kits In Genome Editing Market
8.3.3. France Mutation Detection Kits In Genome Editing Market
8.3.4. Spain Mutation Detection Kits In Genome Editing Market
8.3.5. Italy Mutation Detection Kits In Genome Editing Market
8.3.6. Rest of Europe Mutation Detection Kits In Genome Editing Market
8.4. Asia-Pacific Mutation Detection Kits In Genome Editing Market Snapshot
8.4.1. China Mutation Detection Kits In Genome Editing Market
8.4.2. India Mutation Detection Kits In Genome Editing Market
8.4.3. Japan Mutation Detection Kits In Genome Editing Market
8.4.4. Australia Mutation Detection Kits In Genome Editing Market
8.4.5. South Korea Mutation Detection Kits In Genome Editing Market
8.4.6. Rest of Asia Pacific Mutation Detection Kits In Genome Editing Market
8.5. Latin America Mutation Detection Kits In Genome Editing Market Snapshot
8.5.1. Brazil Mutation Detection Kits In Genome Editing Market
8.5.2. Mexico Mutation Detection Kits In Genome Editing Market
8.6. Rest of The World Mutation Detection Kits In Genome Editing Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Thermo Fisher Scientific
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Takara Bio Inc.
9.2.3. Integrated DNA Technologies, Inc.
9.2.4. Lucigen
9.2.5. Promega Corporation
9.2.6. GenScript
9.2.7. Synthego
9.2.8. New England Biolabs
9.2.9. Applied Biological Materials, Inc. (abm)
9.2.10. Bio-Rad Laboratories
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption